Physician profile
Thomas A Burdon
NPI 1215980347
$3,054.73
in general payments reported to CMS, 2019-2025
10 companies · $649 in 2025
The $649 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $306 · 2021: $161 · 2022: $421 · 2023: $629 · 2024: $490 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294 · Travel and Lodging: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.18 |
| Travel and Lodging | $473.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,105.13 | 2019-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Konect Resilia |
| Abbott Laboratories | $589.51 | 2019-2024 | Epic |
| Intuitive Surgical, INC. | $473.96 | 2025 | |
| Livanova USA, INC. | $365.93 | 2019-2020 | |
| Corcym INC | $223.47 | 2022-2023 | Perceval |
| Kls-Martin L.P. | $108.46 | 2021-2025 | |
| Boston Scientific Corporation | $106.64 | 2019 | |
| Medtronic, INC. | $33.11 | 2025 | Penditure |
| Medtronic Vascular, INC. | $31.78 | 2020 | |
| Getinge USA Sales, LLC | $16.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Burdon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.